Tosner J, Fixa B
Clin Exp Immunol. 1979 Nov;38(2):356-60.
Leucocyte migration inhibition in the presence of tumour crude ovarian tissue antigen was demonstrated in 64.51% of ovarian cancer patients, in 58.18% of other gynaecological carcinoma patients and in 19.04% of healthy individuals. Patients with benign ovarian disease showed 12.5% leucocyte migration inhibition. No significant difference was seen between results obtained in the presence of ovarian carcinoma antigen and normal ovary antigen.
在存在肿瘤粗制卵巢组织抗原的情况下，64.51%的卵巢癌患者、58.18%的其他妇科癌症患者以及19.04%的健康个体出现了白细胞迁移抑制。患有良性卵巢疾病的患者白细胞迁移抑制率为12.5%。在存在卵巢癌抗原和正常卵巢抗原的情况下所获得的结果之间未观察到显著差异。
